Ethypharm SAS
Ethypharm SAS, a prominent player in the pharmaceutical industry, is headquartered in France and operates extensively across Europe and beyond. Founded in 2000, the company has established itself as a leader in the development of innovative medicines, particularly in the fields of pain management and critical care. Ethypharm's core offerings include a range of unique drug delivery systems and specialty pharmaceuticals that address unmet medical needs. The company is recognised for its commitment to quality and innovation, which has led to significant milestones, including strategic partnerships and a robust pipeline of products. With a strong market position, Ethypharm continues to make notable contributions to healthcare, enhancing patient outcomes through its specialised therapeutic solutions.
DitchCarbon Score
How does Ethypharm SAS's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ethypharm SAS's score of 16 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ethypharm SAS's reported carbon emissions
Ethypharm SAS, headquartered in France, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that Ethypharm may still be in the early stages of formalising its climate commitments or reporting on its carbon footprint. In the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their environmental impact, indicating a potential area for future development for Ethypharm.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ethypharm SAS is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
